The oscillating positive expiratory pressure (OPEP) devices market is projected to grow from US$ 125.66 million in 2021 to US$ 179.34 million by 2028; it is estimated to grow at a CAGR of 5.2% during 2021–2028.
Oscillatory positive expiratory pressure (OPEP) devices have been in use as a supplement to traditional chest physiotherapy (CPT) to aid the clearing of respiratory secretions in people who can't cough, especially those with chronic conditions. The use of OPEP devices is still limited in chronic airway disorders such as cystic fibrosis, bronchiectasis, bronchitis, bronchial asthma, and primary ciliary dyskinesia syndrome. In chronic obstructive pulmonary disease (COPD), oscillating positive expiratory pressure (OPEP) devices help with sputum clearance.
The oscillating positive expiratory pressure (OPEP) devices market growth is attributed to the growing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and advancements in medical technologies. However, low awareness and limited access to OPEP devices hinder the growth of the market.
Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Oscillating Positive Expiratory Pressure (OPEP) Devices Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities
Oscillating Positive Expiratory Pressure (OPEP) Devices Market: Strategic Insights

- Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Market Insights
Growing Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Asthma Boosts Market Growth
The incidence of COPD and cystic fibrosis is rising across the world. According to the World Health Organization (WHO), COPD exacerbations are critical events. COPD-related disability and mortality propel the demand for OPEP devices. According to the Center for Disease Control and Prevention (CDC), ~9 million adults were diagnosed with chronic bronchitis in 2018. Also, asthma is becoming common among people of all ages, genders, and races. According to CDC, ~300 million people worldwide suffer from asthma, with the expected addition of 100 million by 2025. The prevalence, severity, and mortality of asthma vary dramatically across the US. Asthma affects more than 25 million people in the US, which equates to 7.7% of adults and 8.4% of children. According to the 2018 Global Asthma Report about Auckland, New Zealand, asthma ranks 16th among the largest causes of disability and 28th among the greatest sources of disease burden, as assessed by disability-adjusted life years. It is common in high-income countries, whereas the majority of asthma-related deaths occur in low- and middle-income countries. Therefore, the rising prevalence of COPD and asthma propels the demand for mucous clearing devices, such as OPEP devices, which bolsters the growth of the oscillating positive expiratory pressure (OPEP) devices market.
Product-Based Insights
The oscillating positive expiratory pressure (OPEP) devices market, based on product, is segmented into mouthpiece PEP devices, face mask PEP devices, and bottle PEP devices. The mouthpiece PEP devices segment held the largest share of the market in 2021. Moreover, it is anticipated to register a CAGR of 5.3% in the market during the forecast period. Mouthpiece PEP helps to remove mucus from the lungs. It can also prevent lung collapse or open up areas that have collapsed. One of the key factors driving the market for mouthpiece PEP devices is the growing elderly population, coupled with higher rates of chronic illnesses such as chronic obstructive pulmonary disease (COPD) and asthma. According to the Centers for Disease Control and Prevention (CDC), ~9 million persons will be diagnosed with chronic bronchitis by 2020, thereby driving the need for mouthpiece devices.
Indication Insights
Based on indication, the oscillating positive expiratory pressure (OPEP) devices market is segmented into chronic obstructive pulmonary disease (COPD), asthma, bronchitis, bronchiectasis, cystic fibrosis, and others. The COPD segment held the largest share of the market in 2021. However, the asthma segment is anticipated to register a CAGR of 6.0% during the forecast period. COPD is a common and treatable disease characterized by progressive airflow limitation and tissue destruction. It is associated with structural lung changes due to chronic inflammation from prolonged exposure to noxious particles or gases, most commonly cigarette smoke. Chronic inflammation causes airway narrowing and decreased lung recoil.
Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the oscillating positive expiratory pressure (OPEP) devices market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally. The market is anticipated to flourish in the coming years due to the development of innovative products by market players.
Oscillating Positive Expiratory Pressure Devices Oscillating Positive Expiratory Pressure (OPEP) Devices Market Regional Insights
The regional trends and factors influencing the Oscillating Positive Expiratory Pressure (OPEP) Devices Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Oscillating Positive Expiratory Pressure (OPEP) Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
Oscillating Positive Expiratory Pressure (OPEP) Devices Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 125.66 Million |
Market Size by 2028 | US$ 179.34 Million |
Global CAGR (2021 - 2028) | 5.2% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
Oscillating Positive Expiratory Pressure (OPEP) Devices Market Players Density: Understanding Its Impact on Business Dynamics
The Oscillating Positive Expiratory Pressure (OPEP) Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

- Get the Oscillating Positive Expiratory Pressure (OPEP) Devices Market top key players overview
Company Profiles
- Allergan Plc.
- PARI GmbH
- Smith’s Medical
- AirPhysio
- D•R BURTON HEALTHCARE
- Medica Holdings, LLC
- CEGLA Medizintechnik GmbH & Co. KG
- Able Healthcare
- Trudell Medical International
- Mercury Medical
Frequently Asked Questions
What is the COVID 19 impact on the oscillating positive expiratory pressure (OPEP) devices market in the coming years?
Which region is expected to witness significant demand for the oscillating positive expiratory pressure (OPEP) devices market in the coming years?
Which are the top companies that hold the market share in oscillating positive expiratory pressure (OPEP) devices market?
Who are the key players in the oscillating positive expiratory pressure (OPEP) devices market?
Which distribution channel held the largest share in the oscillating positive expiratory pressure (OPEP) devices market?
Which product led the oscillating positive expiratory pressure (OPEP) devices market?
Which indication held the largest share in the oscillating positive expiratory pressure (OPEP) devices market?
What are oscillating positive expiratory pressure (OPEP) devices?
What are the driving factors for the oscillating positive expiratory pressure (OPEP) devices market across the globe?
What is the market CAGR value of the oscillating positive expiratory pressure (OPEP) devices market during the forecast period?
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends

















